5-aryl thiazolidine-2,4-diones:: Discovery of PPAR dual α/γ agonists as antidiabetic agents

被引：62
|
作者：
Desai, RC
Han, W
Metzger, EJ
Bergman, JP
Gratale, DF
MacNaul, KL
Berger, JP
Doebber, TW
Leung, K
Moller, DE
Heck, JV
Sahoo, SP
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Metab Disorder, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 16期
关键词：
D O I：
10.1016/S0960-894X(03)00505-5
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel series of 5-aryl tliiazolidine-2,4-diones based dual PPARalpha/gamma agonists was identified. A number of highly potent and orally bioavailable analogues were synthesized. Efficacy study results of some of these analogues in the db/db mice model of type 2 diabetes showed them superior to rosiglitazone in correcting hyperglycemia and hypertriglyceridemia. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2795 / 2798
页数：4
相关论文
共 50 条
  • [1] 5-aryl thiazolidine-2,4-diones as selective PPAR-γ agonists
    Koyama, H
    Boueres, JK
    Han, W
    Metzger, EJ
    Bergman, JP
    Gratale, DF
    Miller, DJ
    Tolman, RL
    MacNaul, KL
    Berger, JP
    Doebber, TW
    Leung, K
    Moller, DE
    Heck, JV
    Sahoo, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1801 - 1804
  • [2] QSAR analysis of 5-aryl thiazolidine-2,4-diones as PPAR-α and PPAR-γ agonists
    Hemlatha, R.
    Soni, L. K.
    Gupta, A. K.
    Kaskhedikar, S. G.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2006, 45 (05): : 1242 - 1249
  • [3] Quantitative Structure Activity Relationship Studies of Some 5-Aryl Thiazolidine-2, 4-Diones as Antidiabetic Agents
    Sonawane, Lalit V.
    Bari, Sanjaykumar B.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2011, 30 (03): : 568 - 570
  • [4] NOVEL THIAZOLIDINE-2,4-DIONES AS POTENT EUGLYCEMIC AGENTS
    HULIN, B
    CLARK, DA
    GOLDSTEIN, SW
    MCDERMOTT, RE
    DAMBEK, PJ
    KAPPELER, WH
    LAMPHERE, CH
    LEWIS, DM
    RIZZI, JP
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) : 1853 - 1864
  • [5] 3-TRICHLOROMETHANESULFENYLOXAZOLIDINE-2,4-DIONES AND THIAZOLIDINE-2,4-DIONES
    CROXALL, WJ
    LO, CP
    SHROPSHIRE, EY
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1953, 75 (21) : 5419 - 5421
  • [6] SUBSTITUTED DIHYDROBENZOPYRAN AND DIHYDROBENZOFURAN THIAZOLIDINE-2,4-DIONES AS HYPOGLYCEMIC AGENTS
    CLARK, DA
    GOLDSTEIN, SW
    VOLKMANN, RA
    EGGLER, JF
    HOLLAND, GF
    HULIN, B
    STEVENSON, RW
    KREUTTER, DK
    GIBBS, EM
    KRUPP, MN
    MERRIGAN, P
    KELBAUGH, PL
    ANDREWS, EG
    TICKNER, DL
    SULESKE, RT
    LAMPHERE, CH
    RAJECKAS, FJ
    KAPPELER, WH
    MCDERMOTT, RE
    HUTSON, NJ
    JOHNSON, MR
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) : 319 - 325
  • [7] Design and synthesis of novel thiazolidine-2,4-diones as hypoglycemic agents
    Datar, Prasanna A.
    Aher, Sainath B.
    JOURNAL OF SAUDI CHEMICAL SOCIETY, 2016, 20 : S196 - S201
  • [8] SYNTHESIS, IN VITRO ANTIOXIDANT AND ANTIDIABETIC ACTIVITY EVALUATION OF NOVEL THIAZOLIDINE-2,4-DIONES
    Swathi, N.
    Himabindu, N.
    Subrahmanyam, C. V. S.
    Satyanarayana, K.
    INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2014, 24 (02) : 145 - 152
  • [9] Aryl 1,3-thiazolidine-2,4-diones acting as KATP channel agonists as a class of potent antidiabetic agents.
    Allen, SH
    Thomas, SA
    Peat, AJ
    Wallace, E
    Garrido, DM
    Truax, JF
    Pfohl, JL
    McKay, C
    Townsend, C
    Worley, JK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U70 - U71
  • [10] Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents
    Wrobel, J
    Li, ZN
    Dietrich, A
    McCaleb, M
    Mihan, B
    Sredy, J
    Sullivan, D
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (07) : 1084 - 1091
12345